Universal BioProducts

Universal BioProducts mission is to pioneer three-dimensional (3D) cell-based screening assays to safely reduce the time-to-market of new drugs.

Universal BioProducts mission is to pioneer three-dimensional (3D) cell-based screening assays to safely reduce the time-to-market of new drugs. There is already a clinical need for increased availability of donor tissue for many surgical procedures. Universal BioProducts will leverage innovative tissue engineering platform technologies to develop and commercialize cellular tissue matrices to meet these needs to ultimately benefit the 3D In Vitro Tissue Engineering market.Our bio scaffold encourages cell infiltration and tissue formation. The tissue is fully regenerated and functional by the time the polymer degrades and is eliminated.Our Universal matrices demonstrate excellent bio compatibility, resistance to calcification, rapid and successful regeneration in viva and possess the same bio mechanical properties as native tissue.The company is initially concentrating on developing a portfolio of products to address various needs in the cardiovascular, neurodegenerative diseases include Parkinson’s, Alzheimer’s, and Huntington’s disease and In vitro 3D market segments.

2021

Fetal Bovine Serum (FBS), Cell culture media, Human Cell line, Type I collagen, 3D Tissue Models